In humans, ARMC5 with four functionally validated SNVs caused the reduced binding to POLR2A and reduced ubiquitination of the latter, suggesting the role of POLR2A as an effector downstream of ARMC5 in causing MM, although further experiments are required to validate this supposition. Here, POLR2A is linked to Miyoshi myopathy.